OBJECTIVE: Insulin resistance (IR) is associated with cardiovascular risk factors including hypertension, dyslipidemia, glucose intolerance and hyperuricemia. The relationship between IR and these cardiovascular risk factors in obese non-diabetic individuals is not well studied. We explore this relationship by comparing the cardiovascular risk factors among insulin-sensitive and insulin-resistant overweight=obese non-diabetic Asian adults in the 1992 National Health Survey of Singapore. DESIGN AND MEASUREMENTS: A total of 3568 subjects were examined in the survey, which involved a combination of disproportionate stratified sampling and systematic sampling. Anthropometric measurements, level of physical activity, blood pressure, insulin, lipid profile, uric acid and standard 75 g oral glucose tolerance test were performed after a 10 h overnight fast. Subjects with diabetes were excluded from the analysis. Homeostasis model assessment (HOMA) was used to assess insulin sensitivity. Relative LDL size was derived from the formula LDL=ApoB. We defined insulin-sensitive individuals as having a HOMA value <1.479 (below median in individuals without diabetes; n ¼ 3226) and overweight=obesity as body mass index (BMI) !25.0 kg=m 2 . RESULTS: There were 156 insulin-sensitive (S) and 679 insulin-resistant (R) overweight=obese individuals, respectively. The groups did not differ in terms of gender and ethnic distribution and level of physical activity. However, subjects in group S were younger than those in group R (mean AE s.d.; 40.1 AE 12.1 vs 42.4 AE 12.7 y; P < 0.05). Group R individuals were also slightly more obese globally and centrally than group S (BMI ¼ 28.2 AE 3.2 vs 27.1 AE 2.8 kg=m 2 ; waist circumference (WC) ¼ 86.7 AE 9.3 vs 82.5 AE 8.3 cm; P < 0.01). There were more subjects with impaired glucose tolerance (IGT) in group R than in group S (29.7 vs 16.0%; P < 0.01). After adjustment for age and indices of global and regional obesity (ie BMI and WC), insulin-resistant individuals showed higher apolipoprotein B, triglyceride, fasting (FPG) and 2 h post-load plasma glucose (2hPG) but lower HDL and LDL size. Further adjustment for FPG, 2hPG and level of physical activity had minimal impact on the results. CONCLUSIONS: Insulin-resistant overweight=obese non-diabetic Asian adults had greater burden of the cardiovascular dysmetabolic syndrome than insulin-sensitive overweight=obese individuals. This could not be fully explained by differences in global and regional obesity, glucose tolerance and level of physical acitivty.
Introduction
Obesity (especially visceral adiposity) is often associated with insulin resistance (IR). 1 Insulin resistance is believed to play a central role in the pathogenesis of the cardiovascular dysmetaboilc syndrome, which is characterized by a constellation of hypertension, dyslipidemia, glucose intolerance and hyperuricemia. 2 The close association between insulin resistance and obesity has made it difficult to establish whether insulin resistance per se (ie independent of obesity) is associated with various components of the cardiovascular dysmetabolic syndrome.
Previous studies suggested that IR might independently be associated with clustering of cardiovascular disease risk factors in non-diabetic subjects 3 as well as subjects with type 2 diabetes. 4 However, these studies recruited middle-aged individuals only; hence, the results could not be extrapolated to the whole adult population. Moreover, certain subgroups in these studies had very few subjects, thereby making definitive conclusions difficult. Recent observational study found fasting hyperinsulinemia (a surrogate for IR) to be a determinant of overall cardiovascular risk independent of obesity among women with polycystic ovary syndrome (PCOS). 5 Moreover, investigators also reported independent association between IR and carotid intima-medial thickness (IMT; which is an early indicator of atherosclerosis 6 ) among hypertensive individuals 7 and normotensive pre-menopausal women. 8 Therefore, the role of IR in cardiovascular diseases deserves further investigation. In this study, we explore the relationship between IR and the cardiovascular dysmetabolic syndrome by comparing the cardiovascular risk factors among insulin sensitive and insulin resistant overweight= obese Asian subjects using the large population based data set from the 1992 National Health Survey of Singapore.
Methods
The study methodology and population characteristics have been described elsewhere. 9 Briefly, 3568 individuals aged 18 -69 y were selected by disproportionate stratified sampling followed by systematic sampling. Minority races (Asian Indians and Malays) were over-sampled to ensure adequate sample size for statistical analysis. Blood pressure and anthropometric data (weight, height, waist circumference (WC)) were measured for all individuals. In addition, blood lipids (total cholesterol (TC), triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C)), glucose (FPG) and insulin were assayed after a 10 h fast. Frequency of physical activity was estimated using standard questionnaire administered by trained interviewers. Participation in any form of sports or exercise which lasted for at least 20 min was considered as an episode of physical activity. Respondents were asked to list all the sports and exercise they participated in the past month. All subjects who were not on oral hypoglycemic agents or insulin were subjected to an oral glucose tolerance test (OGTT). Plasma glucose (2hPG) and serum insulin were re-measured 2 h after the oral glucose challenge.
Glucose measurements were carried out using the glucose oxidase method using the Vitros 700 Chemistry Analyser (Rochester, NY, USA). Insulin was assayed by microparticle enzyme immunoassay using the Abbot AxSYM insulin assay (Chicago, IL, USA). Cholesterol and TG were measured by enzymatic methods using Kodak Ektachem chemistry slides, which were then read on a Vitros 700 Chemistry Analyzer. HDL-C was measured after precipitation with dextran sulfate and magnesium chloride. LDL-C was calculated using Friedewald's formula. Apolipoprotein A and B were measured by APA and APB kits respectively (Beckman Instruments Inc., Ireland). IR was calculated by Homeostasis Model Assessment (HOMA). 10 Relative LDL size was derived from the formula: LDL=ApoB. All subjects with known diabetes on pharmacological treatment or individuals with OGTT results consistent with the diagnosis of diabetes according to the 1998 provisional report of a WHO consultation 11 were excluded from the analysis. This was to avoid the confounding influence of diabetes (which is akin to 'end-stage' of the whole spectrum of glucose intolerance), level of glycemic control and anti-diabetic drugs on the cardiovascular risk factors studied.
We defined overweight=obesity as body mass index (BMI) !25.0 kg=m 2 and insulin-sensitive individuals as having HOMA value <1.479 (below median in individuals without diabetes, n ¼ 3226). The median fasting insulin level in the same cohort was 6.30 mU=l. Hence, insulin-sensitive overweight=obese subjects (S) are those with BMI !25.0 kg=m 2 but with HOMA IR <1.479. On the other hand, those with BMI !25.0 kg=m 2 and HOMA IR !1.479 were considered insulin-resistant overweight=obese subjects (R).
SPSS for Windows version 10.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analyses. Variables which were not normal in distribution were log-transformed to reduce skewness and kurtosis. The transformed figure were subsequently back-transformed for presentation. When analyzing the triglyceride levels, subjects with fasting triglyceride levels above 10.0 mmol=l were excluded (n ¼ 4) since these subjects most probably had chylomichronemia and their fasting triglyceride levels would severely skew the triglyceride levels in a population. Comparison of means was performed using Student's two-tailed t-tests for independent samples. Comparison of medians for non-parametric continuous variables was performed using Mann -Whitney tests. Comparison of proportions was carried out using the chi-square test for independence. Analysis of covariance (ANCOVA) adjusting for age, BMI, WC, fasting plasma glucose (FG) and 2hPG and number of sessions of exercise per month (as covariates), was used for multivariate analysis of cardiovascular risk factors between the S and R groups. In healthy subjects, a threshold effect of obesity on IR has been described, 12 with IR appearing at a BMI > 26.8 kg=m 2 . Hence, a new column of variable (degree of obesity) was created to code those subjects with BMI > 26.8 kg=m 2 as more obese and those with BMI < 26.8 kg=m 2 as less obese. To investigate whether gender, ethnicity and degree of obesity modified the ANCOVA results, the following interaction terms were built into the model in turns: group Â gender, group Â ethnicity, group Â degree of obesity. With only a few exceptions (which were only marginally significant), these interaction terms were mostly not significant, ie in most cases, gender, ethnicity and degree of obesity did not modify the relationship between IR and the various cardiovascular risk factors significantly. Hence, the ANCOVA results were presented without subdividing the subjects into different subgroups of gender, ethnicity or degree of obesity.
Results
There were 156 non-diabetic insulin-sensitive overweight= obese (S) subjects and 679 insulin-resistant overweight= obese (R) subjects. By design, S individuals were more ; WC 86.7 vs 82.5 cm; P < 0.01). There were also more subjects with impaired glucose tolerance (IGT) in R (29.7%) than in S (16.0%; P < 0.01). The two groups, however, did not differ significantly in terms of gender (male: group S, 48.1%; group R, 48.6%; P ¼ 0.91) and ethnic distribution (Chinese vs Malays vs Indians; group S, 51.9% vs 29.5% vs 18.6%; group R, 51.4% vs 22.8% vs 25.8%, respectively P ¼ 0.08). Sixty-six percent and 68.8% of the subjects in groups S and R respectively were physically inactive. For those who participated in regular exercise, the number of sessions of exercise per month did not differ significantly between group S and R (mean number of sessions AE s.d. 3.1 AE 6.6 vs 2.8 AE 6.3, respectively, P ¼ 0.40). Table 1 showed the age-adjusted difference in conventional cardiovascular risk factors (namely, systolic (SBP) and diastolic blood pressure (DBP), apolipoprotein A (ApoA) and B (ApoB), lipid profile (TC, HDL, TG, LDL), calculated relative LDL size, fasting insulin level, glucose tolerance (FPG and 2hPG) and uric acid (UA) levels) between S and R. Besides TC and LDL, all the cardiovascular risk factors were significantly more pronounced in R than in S. Table 2 shows the age-, BMI-and WC-adjusted difference in conventional cardiovascular risk factors between S and R. R individuals continued to show greater burden of the cardiovascular risk factors, ie higher ApoB, TG, fasting insulin level, FPG and 2hPG but lower HDL and LDL size. Table 3 showed the age, BMI-, WC-, FPG-and 2hPG-adjusted difference in conventional cardiovascular risk factors between S and R. The additional adjustment for difference in glycemic status did not change the findings, as shown in Table 2 . Insulin resistance and cardiovascular risk factors S-C Lim et al Table 4 showed the age, BMI-, WC-, FPG-, 2hPG-and level of physical activity-adjusted difference in conventional cardiovascular risk factors between S and R. The additional adjustment for difference in level of physical activity attenuated the observed difference in TG between the groups.
Discussion
In this study, we demonstrated that insulin-resistant overweight=obese Asian subjects carried greater burden of the cardiovascular dysmetabolic syndrome than those who were overweight but insulin sensitive. This was true even after adjusting for differences in age, degree of global and central obesity, glucose tolerance and level of physical activity, thereby suggesting that insulin resistant per se was an independent risk factor for cardiovascular dysmetabolic syndrome in overweight=obese Asian adults.
Our study was unique for the following reasons. Firstly, the subjects belonged to a large population health survey database designed to include a representative cohort of multi-ethnic Asian adults over a broad age range. This was in contrast with previous reports which were either non-population based, 13 age- 4 or gender 5, 8 -selective or predominantly mono-ethnic (ie Caucasians). 20 Therefore, our findings would have good external validity among Asian adult populations. This was particularly noteworthy because our study extended the investigations of IR and cardiovascular diseases to the part of the world where diabetes was projected to become epidemic in the coming decades.
14 Moreover, it was increasingly recognized that IR could be of greater consequence among Asians than Caucasians because at any given degree of obesity, Asians were found to be disproportionately more IR than Caucasians. 15, 16 In other words, if IR were to be independently associated with cardiovascular risk factors, it would have greater clinical significance among Asians than Caucasians. Therefore, the impact of IR on cardiovascular disease among Asians deserved greater attention and our study aptly addressed this important issue. Secondly, by studying the overweight=obese non-diabetic adults discordant for insulin resistance, we clearly demonstrated the independent association between IR and various components of the cardiovascular dysmetabolic syndrome. To the best of our knowledge, this interesting approach had not been adopted previously.
There was considerable controversy over the strength of association between IR and various components of the cardiovascular dysmetabolic syndrome. For instance, previous study suggested an independent association between hypertension and IR. 17 However, other investigators could not demonstrate the same relationship independent of obesity. 3 Our findings were in agreement with the latter, ie the difference in blood pressure between S and R became insignificant after adjusting for age, BMI and WC ( Table 2 ), suggesting that the association between hypertension and IR might be partially dependent on degree of obesity. There were, however, two other possible explanations. Firstly, hypertension may be more strongly associated with IR in lean subjects than in obese subjects. 18, 19 Our study included only overweight=obese individuals, which may explain the weak association of hypertension with IR. Secondly, in our 1992 national health survey, data on the use of blood pressure-lowering agents were not captured. This could potentially dilute the relationship between hypertension between hyperuricemia and IR. Our data showed that the serum uric acid level between groups S and R became similar after adjusting for age, BMI and WC (Table 2) . Hence, our observations support an indirect relationship between hyperuricemia and IR. This is consistent with a recent landmark paper, which suggested that uric acid did not have a causal role in the development of cardiovascular disease but any apparent association with these outcomes was probably due to the association of uric acid levels with other risk factors. 23 In contrast, the independent relationship between IR and dyslipidemia and glucose tolerance was better established. 3,24 -27 Our study re-confirmed the association between IR and FPG and 2hPG (even after adjusting for age, BMI and WC; Table 2 ) and the association between IR and dyslipidemia (namely apolipoprotein B, HDL and LDL particle size) even after adjusting for age, BMI, WC, FPG, 2hPG and level of physical activity (Tables 3 and 4) .
There were, however, three limitations in our study. Firstly, in this very large population survey, detailed dietary analysis could only be limited to a small proportion of the total cohort. Therefore, the importance of dietary factors and IR could not be explored in our study. However, it is known that much controversy exists about the relationship between the amount and types of dietary fat and carbohydrate and IR. 28 Hence, the inclusion of dietary factors in the final analysis may not address the issue adequately. Secondly, radiological imaging of intra-abdominal adiposity using either computerized axial tomography or magnetic resonant imaging would provide a more precise estimate than simple waist circumference. However, such direct measurements were not feasible in the present population studies. In addition, waist circumference is an accepted indirect estimate of central obesity in epidemiological study. 29 Lastly, given the small number of Asian Indians in our cross-sectional study, we were unable to further investigate the relationship between IR and cardiovascular risk factors in each of the ethnic groups.
In conclusion, insulin-resistant overweight=obese nondiabetic Asian adults carried greater burden of the cardiovascular dysmetabolic syndrome compared with those who were overweight but insulin sensitive. This could not be fully explained by differences in global and regional obesity, glucose tolerance and level of physical activity.
